Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8-Reference-Cited by-同舟云学术

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score ≥8

Published:2022-01-18 Issue:4 Volume:29 Page:324-331
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Morozumi Kento¹^ORCID,Mitsuzuka Koji¹^ORCID,Narita Shintaro²,Takahashi Masahiro¹,Kawamura Sadafumi³,Tochigi Tatsuo³,Arai Yoichi³,Hoshi Senji⁴,Shimoda Jiro⁵,Ishidoya Shigeto⁶,Okamoto Teppei⁷,Hatakeyama Shingo⁷,Sakurai Toshihiko⁸,Tsuchiya Norihiko⁸^ORCID,Ohyama Chikara⁷,Habuchi Tomonori²,Ito Akihiro¹

Affiliation:

1. Department of Urology Tohoku University School of Medicine MiyagiJapan

2. Department of Urology Akita University School of Medicine AkitaJapan

3. Department of Urology Miyagi Cancer Center MiyagiJapan

4. Department of Urology Yamagata Prefectural Central Hospital YamagataJapan

5. Department of Urology Iwate Prefectural Isawa Hospital IwateJapan

6. Department of Urology Sendai City Hospital MiyagiJapan

7. Department of Urology Hirosaki University School of Medicine AomoriJapan

8. Department of Urology Yamagata University School of Medicine Yamagata Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14781

Reference29 articles.

1. Risk of death from prostate cancer with and without definitive local therapy when Gleason Pattern 5 is present: a surveillance, epidemiology, and end results analysis;Frandsen J;Cureus,2017

2. National Cancer Institute Surveillance Epidemiology and End Results Program.Cancer stat facts: prostate cancer. [Cited 24 Jul 2021.] Available from URL:https://seer.cancer.gov/startfacts/htmal/prost.html

3. Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches

4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

5. First-Line Treatment of Hormone-Sensitive Metastatic Prostate Cancer: Is There a Single Standard of Care?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?;Cancers;2024-06-26

2. TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis;Clinical Genitourinary Cancer;2023-09